Haematopoietic stem cell transplantation and HIV reservoirs

Posted by •
Study type
Summary
Inclusion Criteria
Participation requirements
Status
Prospective cohort studyThis trial aims to investigate the effect of haematopoietic stem cell transplantation (HSCT) on HIV reservoirs in participants undergoing HSCT for haematologic disorders. The trial builds on promising but mixed results of reducing the HIV burden in HSCT recipients.
  • HIV+
  • ≥ 18 years old
  • planned HSCT
Participants will have additional blood samples drawn at times when other routine blood tests are performed prior to and after HSCT (around 3 tablespoons each time) . Follow up will continue for up to 5 years post transplant.Currently recruiting

Study contact
Alfred Clinical Research on 03 9076 6908

HIV Cure Community Partnership

Hivcure.com.au is the flagship project of the Australian HIV Cure Community Partnership to promote engagement between HIV cure researchers and people living with HIV. Members include NAPWHA, The Doherty Institute for Infection and Immunity, The Kirby Institute, The Alfred Hospital, Living Positive Victoria and Positive Women Victoria.

Must Read

Scroll to Top